In Business

Follow this topic

Bookmark

Record learning outcomes

Independent pharmacy group Allcures has put 15 branches into administration and sold them to another group via a pre-packaged sale, protecting nearly 100 jobs. 

The 15 branches that have been sold to the Wellcare Pharmacy Group are all in the South West and South East of England, with Allcures to retain ownership of its 18 pharmacies in the North West and Yorkshire. 

P3pharmacy understands that Lloyds Bank held the security of the branches that have been put up for sale, with Shawbrook holding the security of the branches in Northern England that have remained within Allcures.

Lloyds Bank took a new all-assets debenture on October 19, 10 days before administrators from RSM UK were appointed. 

Allcures’ most recent Companies House filing, which covers the 12 months to September 30, 2025, shows a loss for the year of £507,993 – significantly more than the £7,030 loss it posted for 2024. 

Broker Christie & Co, which handled the sale of the parts of the pharmacy portfolio that entered administration last week, said the pharmacies – which are located across Essex, East Sussex and Somerset – “occupy a strategic mix of high street, residential and integrated health centre locations”. 

Christie & Co said the acquisition “represents a significant milestone” for the Wellcare Pharmacy Group, which adds the Allcures acquisitions to its existing portfolio of 43 London pharmacies. 

Wellcare Pharmacy managing director Anup Patel said: “We are delighted to welcome the Allcures branches into the Wellcare Pharmacy Group. We look forward to successfully integrating them into our existing network of Wellcare branches.

“This acquisition marks an exciting step forward, creating new opportunities for growth, collaboration, and our continued commitment to delivering excellent patient care.”

Joint administrator Glen Carter commented: “We are pleased to have secured a positive future for 15 community pharmacies through this transaction. The sale safeguards the jobs of nearly 100 employees and, importantly, ensures the continuity of NHS prescription and other essential pharmacy services for the local communities they serve.

“This outcome reflects the considerable efforts of all those involved in completing the transaction while maintaining the continuity of care for patients.”

Jonathan Board, head of pharmacy at Christie & Co, said the sale “represents another significant transaction within the UK pharmacy market,” adding that it “highlights the resilience of the sector and the ongoing demand from ambitious operators looking to expand their footprint through acquisition”.

Mr Board added: “We are pleased to have brokered this deal and are confident that the pharmacies are moving into the hands of an experienced operator well positioned to develop these businesses further.”

Related: Rising drug costs force three pharmacies into administration after missing payroll

Two Scottish pharmacy companies enter administration